Certified by Founder Lodge
Orbital Therapeutics
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $270,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines (excluding RNAi therapeutics) to treat human disease in ways that were not previousl
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 27 ,2023 | Series A | $270,000,000 |
ARCH Venture Partners
Alexandria Real Estate Equities, Inc.
Exor Ventures
Casdin Capital, LLC
Thomas & Moore Strategic Ventures, LLC
Invus Opportunities
Agent Capital
a16z Bio + Health
Redmile Group
Newpath Partners
Abu Dhabi Growth Fund (ADG)
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
